US Stock MarketDetailed Quotes
HURA TuHURA Biosciences
- 6.560
- +1.510+29.90%
Close Nov 29 13:00 ET
- 6.714
- +0.154+2.35%
Post 17:01 ET
277.39MMarket Cap-5606P/E (TTM)
6.990High5.320Low1.88MVolume5.510Open5.050Pre Close12.04MTurnover7.04%Turnover RatioLossP/E (Static)42.28MShares14.59552wk High14.55P/B174.95MFloat Cap2.83552wk Low--Dividend TTM26.67MShs Float238000.000Historical High--Div YieldTTM33.07%Amplitude2.835Historical Low6.411Avg Price1Lot Size
About TuHURA Biosciences Company
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Company Profile
SymbolHURA
Company NameTuHURA Biosciences
Listing DateJul 12, 2016
CEODr. James A. Bianco,M.D.
MarketNASDAQ
Fiscal Year Ends12-31
Address10500 University Drive,Suite 110
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33612
Phone1-813-875-6600
Websitehttp://www.tuhurabio.com
Company Executives
- Name
- Position
- Salary
- Dr. James A. Bianco,M.D.
- Chief Executive Officer and Director
- --
- Daniel Dearborn
- Chief Financial Officer
- --
- Dr. Dennis Yamashita, PhD
- Chief Scientific Officer
- --
- Robert E. Hoffman, C.P.A.
- Director
- --
- Dr. James S.J. Manuso, M.B.A.,PhD
- Independent Director
- --
- George K. Ng
- Independent Director
- --
- Dr. Alan List, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
